Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:57 PM
Ignite Modification Date:
2025-12-24 @ 7:57 PM
NCT ID:
NCT00891904
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically confirmed squamous cell carcinoma of the oral cavity, paranasal sinuses, nasopharynx, larynx, hypopharynx, or oropharynx
* Medically or surgically inoperable disease or patient refuses surgery
* Recurrent disease
* Previously irradiated disease meeting the following criteria:
* Prior radiotherapy completed \> 6 months from re-irradiation
* Prior radiotherapy in the region of the study cancer that would result in overlap of radiation therapy fields
* Majority of the recurrent tumor volume (\> 50%) received prior radiotherapy dose of 30-75 Gy
* No distant metastatic disease
PATIENT CHARACTERISTICS:
* ECOG performance status 0-2
* Life expectancy ≥ 3 months
* Negative pregnancy test
* Fertile patients must use effective contraception during and for ≥ 60 days after completion of study treatment
* No prior allergic reaction to study drugs
PRIOR CONCURRENT THERAPY:
* See Disease Characteristics
* No prior surgical resection of the recurrent primary tumor and/or regional lymphatics
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
120 Years
Study:
NCT00891904
Study Brief:
Protocol Section:
NCT00891904